H. Y. Pan

459 total citations
16 papers, 334 citations indexed

About

H. Y. Pan is a scholar working on Surgery, Molecular Biology and Biotechnology. According to data from OpenAlex, H. Y. Pan has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Biotechnology. Recurrent topics in H. Y. Pan's work include Lipoproteins and Cardiovascular Health (4 papers), Microbial Metabolism and Applications (3 papers) and Cancer, Lipids, and Metabolism (2 papers). H. Y. Pan is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Microbial Metabolism and Applications (3 papers) and Cancer, Lipids, and Metabolism (2 papers). H. Y. Pan collaborates with scholars based in China, United States and Germany. H. Y. Pan's co-authors include Joseph Triscari, Robert E. Botti, Bo Xi, Hongwei Pan, Dayong Zhou, Norihiro Kato, Fumihiko Takeuchi, Giriraj R. Chandak, Jie Mi and Johnson Y. N. Lau and has published in prestigious journals such as Scientific Reports, Diabetologia and Annals of Oncology.

In The Last Decade

H. Y. Pan

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Y. Pan China 7 121 64 57 48 44 16 334
Ming Xiang Zhang China 8 77 0.6× 97 1.5× 13 0.2× 23 0.5× 28 0.6× 8 427
Naoki Miyake Japan 7 49 0.4× 195 3.0× 46 0.8× 25 0.5× 17 0.4× 15 365
Alaa Sada United States 12 172 1.4× 87 1.4× 28 0.5× 94 2.0× 7 0.2× 40 469
T. Royo Spain 13 162 1.3× 122 1.9× 25 0.4× 17 0.4× 68 1.5× 24 474
Y Ishimura Japan 7 39 0.3× 142 2.2× 22 0.4× 33 0.7× 21 0.5× 11 414
Xiaoju Li China 15 136 1.1× 240 3.8× 12 0.2× 30 0.6× 23 0.5× 46 546
Nobutoshi Sugiyama Japan 9 60 0.5× 128 2.0× 23 0.4× 18 0.4× 32 0.7× 17 553
Liuh Ling Goh Singapore 11 29 0.2× 80 1.3× 8 0.1× 36 0.8× 40 0.9× 28 299
Jeremy S. Haley United States 9 36 0.3× 110 1.7× 21 0.4× 65 1.4× 71 1.6× 21 402

Countries citing papers authored by H. Y. Pan

Since Specialization
Citations

This map shows the geographic impact of H. Y. Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Y. Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Y. Pan more than expected).

Fields of papers citing papers by H. Y. Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Y. Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Y. Pan. The network helps show where H. Y. Pan may publish in the future.

Co-authorship network of co-authors of H. Y. Pan

This figure shows the co-authorship network connecting the top 25 collaborators of H. Y. Pan. A scholar is included among the top collaborators of H. Y. Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Y. Pan. H. Y. Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yang, Jialong, H. Y. Pan, Yiran Wang, et al.. (2025). Sesamin promotes the survival of skin flaps in rats by inhibiting ferroptosis through the Nrf2/SLC7A11/GPX4 signaling pathway. Journal of Ethnopharmacology. 357. 120938–120938.
2.
Wang, Kaitao, Ping Xu, Jiapeng Deng, et al.. (2025). Shuxuetong injection promotes skin flap survival by inhibiting pyroptosis mediated by the TLR4/NF-κB/NLRP3 signaling pathway. Journal of Ethnopharmacology. 355(Pt B). 120749–120749.
3.
4.
Yang, Jialong, Kechen Zhang, Ping Xu, et al.. (2025). 2,3,5,4′-Tetrahydroxystilbene-2-O-beta-D-glucopyranoside promotes skin flap survival by promoting mitophagy through the PINK1/Parkin pathway. Journal of Ethnopharmacology. 345. 119587–119587.
5.
6.
Xu, Ping, An Wang, H. Y. Pan, et al.. (2025). Osthole promotes skin flap survival by inhibiting ferroptosis and alleviating pyroptosis. Journal of Ethnopharmacology. 358. 121058–121058.
7.
Ryoo, Baek‐Yeol, Zhenggang Ren, H. Y. Pan, et al.. (2018). Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC). Annals of Oncology. 29. viii207–viii207. 7 indexed citations
8.
Xi, Bo, Fumihiko Takeuchi, Giriraj R. Chandak, et al.. (2012). Common polymorphism near the MC4R gene is associated with type 2 diabetes: data from a meta-analysis of 123,373 individuals. Diabetologia. 55(10). 2660–2666. 53 indexed citations
9.
Floeth, Frank, Anthony L. Asher, Richard D. Bucholz, et al.. (2003). Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma. PubMed. 88. 93–103. 64 indexed citations
10.
Kostis, John B., et al.. (1992). The use of pravastatin alone and in combination with colestipol or probucol in the treatment of primary hypercholesterolemia. 51(3). 487–494. 1 indexed citations
11.
Botti, Robert E., et al.. (1991). Concentrations of Pravastatin and Lovastatin in Cerebrospinal Fluid in Healthy Subjects. Clinical Neuropharmacology. 14(3). 256–261. 110 indexed citations
12.
Pan, H. Y.. (1991). Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase. European Journal of Clinical Pharmacology. 40(S1). S15–S18. 22 indexed citations
13.
Pan, H. Y.. (1991). Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.. PubMed. 40 Suppl 1. S15–8. 36 indexed citations
14.
Pan, H. Y.. (1991). Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase. European Journal of Clinical Pharmacology. 40(1). S15–S18. 6 indexed citations
15.
Pan, H. Y., et al.. (1991). Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.. PubMed. 13(3). 368–72. 4 indexed citations
16.
Lau, Johnson Y. N., et al.. (1990). Wilson's Disease: 35 Years' Experience. QJM. 75(278). 597–605. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Xiang Zhang Breakdown of academic impact, for papers by Naoki Miyake Breakdown of academic impact, for papers by Alaa Sada Breakdown of academic impact, for papers by T. Royo Breakdown of academic impact, for papers by Y Ishimura Breakdown of academic impact, for papers by Xiaoju Li Breakdown of academic impact, for papers by Nobutoshi Sugiyama Breakdown of academic impact, for papers by Liuh Ling Goh Breakdown of academic impact, for papers by Jeremy S. Haley
Rankless by CCL
2026